Literature DB >> 23149440

Therapeutic drug monitoring of common antipsychotics.

Lisbeth Patteet1, Manuel Morrens, Kristof E Maudens, Peter Niemegeers, Bernard Sabbe, Hugo Neels.   

Abstract

The aim of this review is to provide information for interpreting outcome results from monitoring of antipsychotics in biological samples. A brief overview of the working mechanisms, pharmacological effects, drug interactions, and analytical methods of classical and atypical antipsychotics is given. Nineteen antipsychotics were selected based on their importance in the worldwide market as follows: amisulpride, aripiprazole, asenapine, bromperidol, clozapine, flupenthixol, haloperidol, iloperidone, lurasidone, olanzapine, paliperidone, perphenazine, pimozide, pipamperone, quetiapine, risperidone, sertindole, sulpiride, and zuclopenthixol. A straightforward relationship between administered dose, plasma or serum concentration, clinical outcome, or adverse effects is often lacking. Nowadays, focus lies on therapeutic drug monitoring and individualized therapy to find adequate treatment, to explain treatment failure or nonresponse, and to check patient compliance. However, extensive research in this field is still mandatory.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23149440     DOI: 10.1097/FTD.0b013e3182708ec5.

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  18 in total

Review 1.  Clinical Pharmacokinetics of Atypical Antipsychotics: An Update.

Authors:  Massimo Carlo Mauri; Silvia Paletta; Chiara Di Pace; Alessandra Reggiori; Giovanna Cirnigliaro; Isabel Valli; Alfredo Carlo Altamura
Journal:  Clin Pharmacokinet       Date:  2018-12       Impact factor: 6.447

2.  Genotype and co-medication dependent CYP2D6 metabolic activity: effects on serum concentrations of aripiprazole, haloperidol, risperidone, paliperidone and zuclopenthixol.

Authors:  Patteet Lisbeth; Haufroid Vincent; Maudens Kristof; Sabbe Bernard; Morrens Manuel; Neels Hugo
Journal:  Eur J Clin Pharmacol       Date:  2015-10-30       Impact factor: 2.953

3.  Assessment of Antiepileptic Drug Concentrations in HIV-Infected versus HIV-Negative Patients: A Retrospective Analysis.

Authors:  Dario Cattaneo; Sara Baldelli; Andrea Giacomelli; Davide Minisci; Paola Meraviglia; Noemi Astuti; Marta Fusi; Valeria Cozzi; Emilio Clementi; Massimo Galli; Cristina Gervasoni
Journal:  Clin Pharmacokinet       Date:  2019-10       Impact factor: 6.447

4.  Optimal sampling of antipsychotic medicines: a pharmacometric approach for clinical practice.

Authors:  Vidya Perera; Robert R Bies; Gary Mo; Michael J Dolton; Vaughan J Carr; Andrew J McLachlan; Richard O Day; Thomas M Polasek; Alan Forrest
Journal:  Br J Clin Pharmacol       Date:  2014-10       Impact factor: 4.335

5.  Evaluation of the Safety of Quetiapine in Treating Delirium in Critically Ill Children: A Retrospective Review.

Authors:  Christine Joyce; Robert Witcher; Elizabeth Herrup; Savneet Kaur; Elena Mendez-Rico; Gabrielle Silver; Bruce M Greenwald; Chani Traube
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-10-15       Impact factor: 2.576

6.  Genetic and Clinical Factors Affecting Plasma Clozapine Concentration.

Authors:  Eric Olsson; Gunnar Edman; Leif Bertilsson; Dzana Sudic Hukic; Catharina Lavebratt; Sven V Eriksson; Urban Ösby
Journal:  Prim Care Companion CNS Disord       Date:  2015-02-19

7.  Determination of plasma concentration reference ranges for oral aripiprazole, olanzapine, and quetiapine.

Authors:  Julia Korell; Bruce Green; Allan Rae; Bart Remmerie; An Vermeulen
Journal:  Eur J Clin Pharmacol       Date:  2018-02-01       Impact factor: 2.953

8.  Determination of Plasma Concentration Reference Ranges for Risperidone and Paliperidone.

Authors:  J Korell; B Green; B Remmerie; A Vermeulen
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-08-29

9.  Pharmacokinetics of olanzapine long-acting injection: the clinical perspective.

Authors:  Stephan Heres; Susanne Kraemer; Richard F Bergstrom; Holland C Detke
Journal:  Int Clin Psychopharmacol       Date:  2014-11       Impact factor: 1.659

10.  Pharmaceutical studies on and clinical application of olanzapine suppositories prepared as a hospital preparation.

Authors:  Kazuaki Matsumoto; Satoru Kimura; Kenichi Takahashi; Yuta Yokoyama; Masayuki Miyazawa; Satoko Kushibiki; Morio Katamachi; Junko Kizu
Journal:  J Pharm Health Care Sci       Date:  2016-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.